Press release
Peptide Therapeutics Market Annual Growth Report 2025: Growth Drivers, Key Players & Investment Opportunities
Peptide Therapeutics Market
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/peptide-therapeutics-market?kb
Latest M&A
Johnson & Johnson is in talks to acquire Protagonist Therapeutics in a deal likely valued above $4 billion, gaining access to oral peptide drugs targeting IL-23 receptors with applications in psoriasis and inflammatory diseases.
AbbVie is set to acquire Roche spinout Nimble Therapeutics for $200 million, gaining a peptide synthesis and screening platform to expand autoimmune drug pipelines.
Biogen partnered with Dayra Therapeutics on a $50 million oral macrocyclic peptide development program focusing on immunological targets
Key Players:
Eli Lilly and Company, Amgen Inc., Pfizer Inc., Bristol-Myers Squibb Company, Ever Neuro Pharma GmbH, Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Industries Ltd, AstraZeneca PLC, GlaxoSmithKline PLC, and Novo Nordisk AS.
Latest Drugs and Product Launches
Oral peptide drugs gaining momentum include semaglutide formulations such as Rybelsus and dual receptor agonists like Tirzepatide achieving blockbuster status for diabetes and weight management.
New drugs entering advanced stages include icotrokinra (JNJ-2113), an oral peptide targeting interleukin receptors for psoriasis currently in phase 3 trials.
Innovative peptide vaccine platforms targeting cancers and autoimmune diseases are in early clinical evaluations.
Growth Forecast Projection:
The Global Peptide Therapeutics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Peptide Therapeutics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=peptide-therapeutics-market?kb
Key Segmentation:
By Type: (Patented, Generic)
By Application: (Cancer, Cardiovascular Diseases, Metabolic Diseases, Central Nervous System Disorders, Respiratory Diseases, Infectious Diseases)
By Route of Administration: (Oral Route, Parenteral Route)
By Technology: (Solid Phase Peptide Synthesis (SPPS), Liquid Phase Peptide Synthesis (LPPS), Hybrid Phase Peptide Synthesis (HPPS))
Regional Analysis for Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Peptide Therapeutics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Peptide Therapeutics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/peptide-therapeutics-market?kb
Latest Investments
CordenPharma is investing approximately €900 million to expand large-scale peptide manufacturing capacity in the US and Europe, supporting GLP-1 and other peptide manufacturing contracts totaling €3 billion.
BioMed X partnered with Novo Nordisk for innovation in oral peptide drug delivery technologies aiming at improving bioavailability and patient adherence.
Investor interest in peptide therapeutics remains robust, with venture capital focused on next-generation drug delivery, stability enhancement, and dual receptor targeting peptides
Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/peptide-therapeutics-market?kb
Latest Project Hubs
Expansion of peptide manufacturing hubs in Colorado (USA) and Europe by contract development and manufacturing organizations (CDMOs) is underway to meet growing commercial demand for high-quality peptides.
Research collaborations and innovation ecosystems are strong in Europe, the US, and Asia, fostering new peptide therapeutic modalities and oral delivery platforms.
Latest Clinical Trials
Numerous phase 3 trials of oral and injectable peptides focus on metabolic diseases, cancer immunotherapy, and autoimmune disorders, with several compounds nearing market approval.
Promising early-phase data for peptide vaccines stimulating immune response in fibrolamellar hepatocellular carcinoma and other refractory cancers highlight therapeutic potential for peptides in oncology.
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Therapeutics Market Annual Growth Report 2025: Growth Drivers, Key Players & Investment Opportunities here
News-ID: 4286449 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Health And Wellness Products Market to Hit USD 10.7 Billion by 2030, North Ameri …
Leander, Texas- Global Health And Wellness Products Market reached US$ 6.8 billion in 2022 and is expected to reach US$ 10.7 billion by 2030, growing with a CAGR of 5.8% during the forecast period 2024-2031.
The market is growing due to increased consumer health consciousness, an aging population, rising disposable incomes, and technological advancements like wearable devices. This shift towards preventive and holistic health management, coupled with the prevalence of chronic…
Asia-Pacific Leads Polymeric Adsorbents Market with 40% Share, Market Projected …
Leander, Texas - The Global Polymeric Adsorbents Market is valued at approximately USD 192.57 million in 2025 and is projected to reach about USD 402.40 million by 2032, growing at a CAGR of around 11.12% during the forecast period from 2025 to 2032.
This significant growth is driven by increasing industrial applications in pharmaceuticals, water treatment, food and beverage processing, and environmental remediation.
Get a Free Sample PDF Of This Report…
Automotive Logistics Industry Sector Annual Growth 2025: Industrial Share, Futur …
global automotive logistics market size was worth US$ 111.59 Billion in 2024 and is estimated to reach US$ 203.54 Billion by 2032, growing at a CAGR of 8.09% during the forecast period (2024-2032).
United States Automotive Logistics Market size in 2024: USD 39.42 B and projected to USD 61.73 B by 2030 with a CAGR of 7.8% (2025-2030).
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate…
Feminine Hygiene Products Market Surges From US$ 24.60 Billion to US$ 43.13 Bill …
The Global Feminine Hygiene Products Market reached US$ 24.60 billion in 2023, increased to US$ 25.94 billion in 2024, and is projected to reach US$ 43.13 billion by 2033, registering a CAGR of 6.6% during 2025-2033. Steady growth is driven by rising awareness of women's health, improved access to hygiene products, and increasing adoption of sustainable and organic menstrual care solutions across both developed and emerging markets.
The market is being…
More Releases for Peptide
Copper Peptide GHK-Cu Market: Empowering Beauty and Health Innovations with Adva …
The global copper peptide GHK-Cu market is poised for transformative growth as innovative cosmetic and pharmaceutical formulations increasingly incorporate these bioactive peptides to promote skin rejuvenation, wound healing, and overall wellness. Driven by technological advancements, growing consumer awareness of anti-aging solutions, and an expanding portfolio of product applications, the market is set to evolve rapidly in the coming years. This industry provides an in-depth analysis of market information, key growth…
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be?
In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension…
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights:
• Global Peptide Cancer Drug Market Insight By Region & Indication
• Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion
• Approved Peptide Cancer Drugs: > 30 Drugs
• Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis
• Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase
• Insight On Peptide Cancer Drugs In Clinical Trials: >…
Growing Adoption of Synthetic Peptide Drugs Driving Peptide Therapeutics Market …
Peptide Therapeutics Market size was valued at USD 40.69 billion in 2019 and is poised to grow from USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031).
[https://www.skyquestt.com/report/peptide-therapeutics-market] size was valued at USD 43.11 billion in 2023 to USD 68.4 billion by 2031, growing at a CAGR of 5.94% in the forecast period (2024-2031). The increasing prevalence of…
Global Adjuvant Peptide Market Size,Share, Research and Forecast,2023-2028| Pept …
The global Adjuvant Peptide market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Adjuvant Peptide market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global…
Peptide Modifications For PEGylation
PEGylation is the process of covalently attaching polyethylene glycol (PEG) polymer chains to peptides. By increasing their molecular mass and shielding them from proteolytic enzymes, PEGylation improves the pharmacokinetics of peptides and proteins. PEGylation reduces renal clearance and results in more sustained absorption after subcutaneous administration, as well as restricted distribution. PEGylations have been shown to significantly improve water solubility, biocompatibility, immunogenicity, and other physico-chemical properties. It is an established…
